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ABSTRACT
Background Adipose tissue is a primary site of obesity-induced inflammation, which is emerging as an
important contributor to obesity-related diseases such as type 2 diabetes. Dietary fibre consumption appears to
be protective. Short-chain fatty acids, e.g. propionic acid, are the principal products of the colonic fermentation
of dietary fibre and may have beneficial effects on adipose tissue inflammation.
Materials and methods Human omental adipose tissue explants were obtained from overweight (mean BMI
28Æ8) gynaecological patients who underwent surgery. Explants were incubated for 24 h with propionic acid.
Human THP-1 monocytic cells were differentiated to macrophages and incubated with LPS in the presence and
absence of propionic acid. Cytokine and chemokine production were determined by multiplex-ELISA, and mRNA
expression of metabolic and macrophages genes was determined by RT-PCR.
Results Treatment of adipose tissue explants with propionic acid results in a significant down-regulation of
several inflammatory cytokines and chemokines such as TNF-a and CCL5. In addition, expression of lipoprotein
lipase and GLUT4, associated with lipogenesis and glucose uptake, respectively, increased. Similar effects on
cytokine and chemokine production by macrophages were observed.
Conclusion We show that propionic acid, normally produced in the colon, may have a direct beneficial effect on
visceral adipose tissue, reducing obesity-associated inflammation and increasing lipogenesis and glucose
uptake. Effects on adipose tissue as a whole are at least partially explained by effects on macrophages but likely
also adipocytes are involved. This suggests that, in vivo, propionic acid and dietary fibres may have potential in
preventing obesity-related inflammation and associated diseases.
Keywords Adipose tissue, dietary fibre, inflammation, propionic acid, short-chain fatty acids.
Eur J Clin Invest 2012; 42 (4): 357–364
Introduction
During obesity, adipose tissue can be a site of low-grade inflam-
mation [1]. In obese adipose tissue, the production of several
inflammatory cytokines and chemokines and the infiltration of
inflammatory cells is increased [2]. Adipose tissue inflamma-
tion is associated with the pathogenesis of obesity-related dis-
eases such as type 2 diabetes and cardiovascular diseases [3,4].
A large body of evidence indicates that dietary fibre consump-
tion has a profound effect on human health. This includes the
increase in postmeal satiety and the decrease in body weight,
fat mass and the severity of type 2 diabetes [5–10]. These effects
may be caused via colonic fermentation of dietary fibre. Various
metabolites are produced, such as short-chain fatty acids
(SCFA), which are absorbed by the host and influence its
energy homoeostasis [6,11,12]. Colonic metabolism can influ-
ence the development of obesity and its associated diseases
through different mechanisms, recently reviewed [11,13].
It has been demonstrated that SCFA in particular acetate,
butyrate and propionate inhibit inflammation. However,
most of the studies focused on butyrate and to a lesser
extent on acetate, while the effects of propionic acid (PA)
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in humans have remained largely unexplored [14,15].
Therefore, we focused on PA. Fermentation of dietary fibre
and ⁄ or resistant starch by the colonic microbiota is the
primary source of PA. Despite the technical and ethical
issues involved, a few studies measured the quantities of
different SCFA in human portal vein and peripheral blood.
PA quantity in the human colon was reported to be
20 mmol ⁄kg and to depend on the balance between produc-
tion and absorption [16,17], the type of microbiota, the
quantity and the type of the substrate and the gut transit
time [18]. The majority of the PA produced in the colon is
absorbed, passes the colonocytes and the viscera, and
drains into the portal vein. PA can be partially metabolized
by colonocytes; however, the quantity that is utilized by
visceral tissues, e.g. visceral adipose tissue, has not been
examined yet. The quantity of PA in the portal vein in
nonfasting humans was demonstrated to be approximately
0Æ1 mM; while it was threefold lower in blood derived from
fasting humans [16,19,20]. Around 90% of PA in the portal
vein is metabolized by the liver and the rest is transported
into peripheral blood [18], where a concentration of 6 lM
in humans was reported [19,21–23], far in excess of that of
butyrate, but lower than that of acetate.
Propionic acid and other SCFA are potent and efficacious
ligands for the G-protein-coupled receptors 41 (GPCR41)
and 43 (GPCR43) [24]. GPCR43 knockout mice showed
exacerbated inflammation in models of inflammatory dis-
eases, i.e., colitis, arthritis and asthma [25]. These experi-
ments strongly support the role of colonic PA production
as an important anti-inflammatory mechanism. In addition,
in previous experiments, we have shown ex vivo, in human
adipose tissue explants, that PA influences adipokine secre-
tion by stimulating leptin and reducing resistin expression
[26], suggesting a role in satiety and inflammation. As adi-
pose tissue is a major contributor to obesity-induced low-
grade inflammation [27] and as both GPCR receptors of PA
are present on adipose tissue [26], one could envision that
colonic microbiota metabolism, via PA, influence obesity-
induced low-grade inflammation in adipose tissue. There-
fore, in this study, we investigated the influence of PA on
several inflammatory and metabolic parameters in human
omental adipose tissue (OAT) explants and in macrophages.
We show that, in OAT, PA reduced the production of a
panel of chemokines and cytokines and adipose tissue
macrophage markers as well as expression of genes
involved in glucose and lipid metabolism. Thus, providing
evidence that a microbial metabolite, in casu PA, is able to
modulate the inflammatory reaction in human adipose tis-
sue as well as glucose and lipid metabolism. This suggests
that PA and dietary fibres may have potential in preventing
obesity-related inflammation and associated diseases.
Materials andmethods
Materials
Gentamycin, glucose, LPS and PA were purchased from Sigma
(Zwijndrecht, The Netherlands). M199 media was purchased
from Invitrogen (Breda, the Netherlands). CD16A, CD31,
CD163 and MMP-9 primers were purchased from Applied
Biosystems (Nieuwerkerk a ⁄d IJssel, the Netherlands), whereas
the rest of the primers were purchased from Biolegio
(Nijmegen, the Netherlands).
Human adipose tissue culture
Omental adipose tissue explants were obtained from women
who underwent surgery for gynaecologic disorders such as
myoma and prolapse. None of the women had diabetes and
their anthropometric indices are presented in Table 1. The
study was approved by the local medical ethical committee.
Adipose tissue culture was performed as described previously
[26] with slight modifications. Briefly, adipose tissue explants
were transported from the operating room to the laboratory in
transport buffer (PBS, 5Æ5 mM glucose, 50 lg ⁄mL gentamicin).
Immediately upon arrival, tissue was transferred to a Petri dish
containing 20 mL of PBS and was finely minced in 20–80 mg
pieces using scissors. Tissue pieces were extensively washed
with PBS over a filter. The pieces were transferred to a tube
containing 50 mL of PBS and centrifuged for 1 min at 277 g to
remove red blood cells and debris. The weight of the tissue was
determined, and pieces were distributed over 6-well plates
(0Æ5 g ⁄ 5 mL). The dishes were incubated at 37 C at 5% CO2.
The medium was renewed after 1, 18Æ5, 22Æ5 and 26Æ5 h to
remove serum proteins. After the last washing step, tissue
explants were incubated for 24 h with or without 3 mM PA.
Subsequently, tissue pieces were snap frozen in liquid nitrogen
and then stored at )80 C until RNA was isolated. Media
samples were stored at )80 C prior to ELISA measurements.
Cell culture
Human THP-1 monocytic cell line was maintained in RPMI-
1640 phenol red-free media supplemented with 10% FBS,
Table 1 Anthropometric indices of adipose tissue donors
Subject ID BMI WHR WC
S-1 30Æ44 0Æ82 95
S-2 27Æ46 0Æ86 90
S-3 30Æ85 0Æ93 95
S-4 31Æ89 0Æ91 104
S-5 23Æ59 0Æ84 82
BMI, body mass index; WHR, waist hip ratio; WC, Waist circumference.
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100 U ⁄mL of penicillin and 100 lg ⁄mL of streptomycin in
humid atmosphere containing 5% CO2 at 37 C. To induce
monocyte-macrophage differentiation, THP-1 cells were seeded
at a concentration of 5 · 105 cells ⁄mL and were differentiated
with 10 ng ⁄mL PMA for 48 h. THP-1-derived macrophages
were treated for 2 h, in triplicate, with 1 lg ⁄mL LPS alone or in
combination with various concentrations of PA (0Æ001, 0Æ01, 0Æ1,
1 and 10 mM).
Relative Q-PCR analysis
Total RNA was isolated by the RNeasy lipid tissue mini kit,
and cDNA was synthesized using the Quantitect kit (both from
Qiagen, Venlo, the Netherlands). Relative quantification of
genes were performed in triplicate with the ABI 7900HT
sequence detection system for relative real-time polymerase
chain reaction (Taqman; Applied Biosystems) using the DDCT
method. The primers pairs and probes used are displayed in
Table 2. Stability of several housekeeping genes was assessed
by GENORM analysis software (http://medgen.ugent.be/
~jvdesomp/genorm/) [28]. GAPDH was chosen as the most
stable housekeeping gene expressed in adipose tissue. PCR was
performed using TaqMan Universal Master Mix in a total reac-
tion mix volume of 10 lL. The PCR conditions were 15 min at
95 C, 40 cycles of 15 s at 95 C followed by 1 min at 62 C.
Protein quantification
Secreted chemokines and cytokines were measured in culture
media by multiplex-ELISA according to the manufacturer’s
description (Bio-Rad, Hercules, CA, USA). TNF-awas also
determined by ELISA (Duoset; R&D Systems, Minneapolis,
MN, USA). If necessary, samples were concentrated ten times
using ultra filtration (Sartorius Stedim Biotech, Goettingen,
Germany).
Statistics
Comparison between two groups was performed by two-sided
paired Student’s t-test. Results were considered to be statisti-
cally significant at P < 0Æ05.
Results
Propionic acid inhibits cytokine and chemokine
secretion by human adipose tissue
We previously showed that 3 mM PA is optimal for inducing
leptin production in human adipose tissue [26]. Because resistin
has been associated with an inflammatory response [29], we
investigated the effect of PA on the basal levels of several
chemokines and cytokines in human OAT explants derived
from five women with BMI’s ranging from 23Æ6 to 31Æ9
(Table 1). Treatment with 3 mM PA for 24 h significantly inhib-
its basal secretion of interleukin-4 (IL-4), interleukin-10 (IL-10),
tumour necrosis factor-a (TNF-a), granulocyte colony-stimulat-
ing factor (G-CSF), interferon-gamma-induced protein (IP-10),
macrophage inflammatory proteins-1a and -1b (MIP-1a and
MIP-1b) and CCL5 (RANTES). Interleukin-1b (IL-1b) and inter-
leukin-8 (IL-8) and monocyte chemo tactic protein-1 (MCP-1)
were not influenced, while interleukin-12 (IL-12) and interleu-
kin-13 (IL-13) were not detectable (Fig. 1). Absolute concentra-
tions are shown in Table 3. The largest decrease was found for
IL-10 (68Æ1%) followed by IP-10 (60Æ1%), TNF-a (59Æ9%) and
RANTES (58Æ7%). G-CSF, MIP-1b and MIP-1awere reduced by
50Æ4%, 46Æ3% and 35Æ7%, respectively. Only a marginal decrease
in IL-4 (14Æ8%) was detected.






GGT GAA GGT CGG AGT CAA CG
GAPDH
backward
ACC ATG TAG TTG AGG TCA ATG AAG G
GAPDH probe CGC CTG GTC ACC AGG GCT GC
GLUT4
forward
GCT GTG GCT GGT TTC TCC AA
GLUT4
backward
CCC ATA GCC TCC GCA ACA TA
GLUT4 probe CGA GCA ACT TCA TCA TTG GCA TGG GTT
LPL forward TGG AGA TGT GGA CCA GCT AGT G
LPL backward CAG AGA GTC GAT GAA GAG ATG AAT G
LPL probe CTC CCA CGA GCG CT
SREBP1c
forward
GGA TTG CAC TTT CGA AGA CAT G
SREBP1c
backward
AGC ATA GGG TGG GTC AAA TAG G
SREBP1c
probe
CAG CTT ATC AAC AAC CAA GAC AGT GAC TTC CC
CD163
forward
TGC AGA AAA CCC CAC AAA AAG
CD163
backward
CAA GGA TCC CGA CTG CAA TAA




LPL, lipoprotein lipase; SREBP-1c, sterol regulatory-element-binding protein-
1c. *ID numbers of primer sets from Applied Biosystems.
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Propionic acid stimulates expression of sterol
regulatory-element-binding protein-1c and key
metabolic genes in human adipose tissue
Glucose and lipid uptake are key metabolic processes executed
by adipose tissue. Therefore, we measured the effect of PA on
the expression of the insulin responsive glucose transporter
(GLUT-4), lipoprotein lipase (LPL) as well as the transcription
factor sterol regulatory-element-binding protein-1c (SREBP-1c)
in four explants in triplicate (Fig. 2a). Both GLUT-4 and LPL
are regulated by SREBP-1c [30,31]. We found that PA up-regu-
lates GLUT-4, LPL and SREBP-1c mRNA expression by 54Æ4%,
55Æ5% and 36Æ1%, respectively.
Propionic acid inhibits expression of macrophage-
specific genes in human adipose tissue
To determine whether the effects of PA on chemokine and
cytokine production could involve adipose tissue macrophages,
we determined the effect of PA on established macrophage
markers. Human adipose tissue explants obtained from four
women were incubated with or without 3 mM PA in triplicate,
and mRNA expression of the human macrophage-specific
markers CD163, CD16A and metalloproteinase-9 (MMP-9) as
well as the endothelial marker CD31 was determined (Fig. 2b).
PA down-regulated these genes by 44Æ7%, 29Æ7%, 59Æ3% and
14Æ5%, respectively.
Propionic acid inhibits cytokine and chemokine
secretion by human macrophages
The inhibition of expression of macrophage marker genes in
adipose tissue by PA suggests that adipose tissue macrophages
are a target for PA in adipose tissue. Therefore, we studied the
effect of PA on cytokine and chemokine production by THP-1-
derived human macrophages. First, we determined expression
of the SCFA receptors GPCR41 and GPCR43 in these macro-
phages (Fig. 3a). Both receptors are expressed. GPCR43 is






















Control IL-1β IL-4 IL-8 IL-10 G-CSF
(IP-10)
CXCL10 MCP-1 MIP-1α
Figure 1 The effect of propionic acid (PA) on the secretion of chemokines and cytokines by human omental adipose tissue (OAT).
OAT explants of five overweight subjects were incubated in triplicate with or without 3 mM PA for 24 h. The secretion of the listed
chemokines and cytokines were determined in the media by multiplex-ELISA. Results are depicted as relative quantities (RQ)
compared with the control (without PA). The measured concentrations are listed in Table 3. Error bars represent ± SD. *P < 0Æ05
vs. control.
Table 3 Effect of PA on cytokine and chemokine secretion by
human omental adipose tissue
Control PA
IL-1b 6Æ62 ± 0Æ59 6Æ49 ± 0Æ68
IL-4 1Æ42 ± 0Æ12 1Æ21 ± 0Æ21
IL-8 64254 ± 21049 48711 ± 31752
IL-10 30Æ1 ± 42Æ1 9Æ60 ± 5Æ87
IL-12 N.D. N.D.
IL-13 N.D. N.D.
G-CSF 256 ± 222 127 ± 150
CXCL10 (IP-10) 1510 ± 911 589 ± 566
MCP-1 5439 ± 4386 36710 ± 1198
MIP-1a 84Æ6 ± 32Æ5 54Æ4 ± 34Æ4
MIP-1b 382 ± 101 205 ± 89
CCL5 (RANTES) 252 ± 120 104 ± 61Æ1
TNF-a 12Æ2 ± 17Æ1 4Æ89 ± 6Æ69
G-CSF, granulocyte colony-stimulating factor; N.D., not detectable; PA,
propionic acid. Concentrations in pg ⁄ mL in 10-fold concentrated media.
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determined the effect of PA on LPS-induced TNF-a production.
Macrophages were incubated in triplicate with 1 lg ⁄mL LPS, to
induce TNF-a, and with different concentrations of PA (0Æ001,
0Æ01, 0Æ1, 1 and 10 mM) for 2 h. A gradual decrease in TNF-a
secretion was observed with increasing PA concentrations,
which became significantly different with 100 lM PA (26Æ6%
inhibition) (Fig. 3b). A maximal inhibition of TNF-a production
of 62Æ5% was found with 10 mM PA. The latter condition was
used in a new experiment where we determined the effect of
PA on the production of a number of cytokines and chemokines
by macrophages (Fig. 4). PA significantly inhibited the secre-
tion of IL-10, G-CSF, MCP-1, CCL5 and TNF-a. while IL-1b,
IL-8, IP-10, MIP-1a and MIP-1bwere not influenced. IL-12 and
IL-13 were not detectable. Absolute concentrations are shown
in Table 4. The largest decrease was found for IL-10 (77Æ5%)
followed by G-CSF (46Æ9%) MCP1 (44Æ7%) TNF-a (36Æ0%) and
CCL5 (28Æ6%). In contrast to adipose tissue (Fig. 1), an increase
in IL-4 (61Æ2%) was detected. However, absolute IL-4
concentrations were low (Table 4).
Discussion
It is becoming clear that especially (prebiotic) diets, favouring
the production of SCFA by the colonic microbiota, are
associated with a reduction in obesity-related diseases























Figure 2 The effect of propionic acid (PA) on the expression of
key metabolic genes and macrophage-specific markers in adi-
pose tissue. Omental adipose tissue explants of five over-
weight subjects were incubated in triplicate with or without
3 mM PA for 24 h. mRNA expression levels were determined
by RT-PCR and depicted as relative quantities (RQ) compared
with the control (without PA). (a) The effect of PA on mRNA
expression of GLUT4 (glucose metabolism) and LPL (lipogene-
sis) and the transcription factor SREBP1c. (b) The effect of PA
on mRNA expression of the macrophage markers CD163,
CD16A and MMP-9 and the endothelial marker CD31 (PECAM-
1) in adipose tissue. Error bars represent ± SD. *P < 0Æ05
**P < 0Æ001 vs. control.
0


























Figure 3 Expression of short-chain fatty acid receptors in
human macrophages and inhibition of LPS-induced TNF-a
secretion by propionic acid (PA). (a) The level of mRNA expres-
sion of G-protein-coupled receptor 43 (GPCR43) in THP-1-
derived macrophages was determined by RT-PCR and depicted
as a relative quantity (RQ) compared with GPCR41. (b) THP-1-
derived macrophages were incubated in triplicate with
1 lg ⁄mL LPS alone or in combination PA (0Æ001–10 mM) for
two hours. Dose–response curves of PA on TNF-a secretion
from THP-1-derived macrophages. TNF-a in the media was
determined by ELISA. Error bars represent ± SD. *P < 0Æ05 vs.
control (LPS alone).
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colon-produced SCFA. Indeed, we previously showed that both
human subcutaneous and OAT express the SCFA receptors
GPCR41 and GPCR43 and that PA is able to induce leptin and
reduce resistin production while leaving adiponectin unaf-
fected [26]. In the present study, we studied the immune-modu-
lating effect of PA in explants of human OAT from overweight
persons (average BMI 28Æ8), which produce measurable
amounts of cytokines and chemokines and show that PA is able
to inhibit their production. PA could inhibit the production of
inflammatory (TNF-a) as well as anti-inflammatory (IL-4, IL-10)
cytokines. Furthermore, production of a number of chemokines
(IL-8, MIP-1a and MIP-1b, CCL5 and CXCL10) was decreased
by PA. Chemokines are crucial for the attraction of mononu-
clear cells from the circulation into adipose tissue [33,34]. The
PA-induced inhibition of chemokines may reduce the infiltra-
tion of immune cells into adipose tissue and therefore may
suppress the propagation of adipose tissue inflammation in
obese adipose tissue [35]. Therefore, although some anti-inflam-
matory cytokines are also affected, results suggest that the net
effect of PA on adipose tissue is anti-inflammatory. Besides this
immune-modulating effect of PA, we also show that PA affects
two major metabolic pathways in adipose tissue namely lipo-
genesis and glucose metabolism because both LPL and GLUT4
expression were found to be up-regulated by PA. Expression of
LPL and GLUT4 is known to be regulated by SREBP1c [30,31].
Indeed, we found an increased SREBP1c expression after PA
stimulation, suggesting that SREBP1c is responsible for the
increased expression of LPL and GLUT4. These data suggest
that besides an anti-inflammatory effect, PA also has an, insulin
like, anabolic effect, stimulating two important metabolic
pathways that are also stimulated by insulin. In fact, although
speculative, PA may possibly stimulate glucose and lipid
uptake independently of the insulin signalling pathway via
direct stimulation of SREBP1c. This would implicate that PA
may be able to stimulate glucose and lipid uptake in insulin
resistant cells ⁄ tissues. If so, this might improve blood glucose
levels in insulin resistant ⁄patients with type 2 diabetes.
We also show that the expression of CD163, CD16A and
MMP-9, specific macrophage marker genes, is affected by PA
suggesting that macrophages are target cells for SCFA within
adipose tissue. Therefore, we conducted studies with in vitro
differentiated human THP-1 macrophages. Although it would
be better to use isolated human adipose tissue macrophages,
these are very difficult to isolate with sufficient purity and
quantity to perform these experiments. We show that THP-1-
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Figure 4 The effect of propionic acid (PA) on the LPS-induced secretion of chemokines and cytokines by human macrophages.
THP-1-derived macrophages were incubated in triplicate with 1 lg ⁄mL LPS alone or in combination with 10 mM PA for 2 h. Chemo-
kines and cytokines in the media were determined by multiplex-ELISA. Results are depicted as relative quantities (RQ) compared
with control (LPS alone). Measured concentrations are listed in Table 4. Error bars represent ± SD. *P < 0Æ05 vs. control.
Table 4 Effect of PA on cytokine and chemokine secretion by
human THP-1 macrophages
LPS LPS + PA
IL-1b 171 ± 267 194 ± 403
IL-4 0Æ25 ± 0Æ23 0Æ41 ± 0Æ13
IL-8 761 ± 4590 420 ± 870
IL-10 4Æ26 ± 6Æ70 0Æ96 ± 0Æ46
IL-12 N.D. N.D.
IL-13 N.D. N.D.
G-CSF 1Æ55 ± 1Æ68 0Æ82 ± 0Æ98
CXCL10 (IP-10) 26Æ7 ± 43Æ5 25Æ4 ± 82Æ4
MCP-1 8Æ46 ± 7Æ47 4Æ68 ± 1Æ00
MIP-1a 134 ± 445 95Æ3 ± 215
MIP-1b 207 ± 712 158 ± 286
CCL5 (RANTES) 255 ± 310 182 ± 50Æ6
TNF-a 2046 ± 1428 1308 ± 494
G-CSF, granulocyte colony-stimulating factor; N.D., not detectable;
PA, propionic acid. Concentrations in pg ⁄ mL.
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3Æ3-fold higher expression of GPCR43 compared with GPCR41.
Furthermore, we found a dose-dependent inhibition of
LPS-induced TNF-a secretion by PA. A significant inhibition of
26Æ6% was already obtained with 100 lM PA. Inhibition was
maximal with 10 mM PA. Also with an extended set of cyto-
kines and chemokines, PA shows similar reductions in IL-10,
G-CSF, CCL5 and TNF-a compared with experiments with adi-
pose tissue. In addition, in macrophages, a reduction in MCP-1
was seen, which was not observed in adipose tissue. In contrast
with adipose tissue, CXCL10, MIP-1a and MIP-1bwere not
changed in macrophages. Furthermore, IL-4 was increased by
PA treatment in macrophages, while a slight decrease was
observed in adipose tissue. The relevance of this observation is
unclear because levels of IL-4 produced by adipose tissue and
macrophages were very low (Tables 3 and 4). Anti-inflamma-
tory properties of PA have also been observed in a colon
carcinoma cell line and a mechanism involving inhibition of the
NF-jB transcription factor was suggested [36], possibly via
suppressed proteasome function which prevents breakdown of
the inhibitory IkB protein [37]. The differences between effects
of PA on macrophages and on adipose tissue as a whole may be
explained by additional effects of PA on adipocytes, the major
cell type in adipose tissue. We recently showed that adipocytes
may act as immune cells and produce a whole spectrum of
cytokines and adipokines upon an inflammatory challenge [38]
under which the set of inflammatory mediators measured in
the current study. Therefore, the net effect of PA on adipose
tissue may likely consist of effects on adipocytes as well as
macrophages.
In summary, our data show that PA has anti-inflammatory
effects on OAT from overweight subjects, accompanied by
improved expression of LPL and GLUT4, associated with
lipogenesis and glucose uptake, respectively. These effects are
partially explained by effects on macrophages but likely also
adipocytes are involved. We hypothesize that PA, produced in
the colon, may have a direct beneficial effect on visceral adipose
tissue by reducing obesity-associated inflammation and
increasing lipogenesis and glucose uptake. These data corre-
spond well with studies that show that diets that are likely to
enhance the production of PA by the microbiota correlate with
lower incidence and better outcome of metabolic syndrome and
other obesity-related diseases [15,39]. The physiological rele-
vance of these findings has to be determined in future studies.
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